Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Predictive Oncology Inc. Director's Dealing 2015

Apr 7, 2015

35106_dirs_2015-04-07_8af567e6-699c-4d7c-be77-ad07d5d16b08.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2015-03-31

Reporting Person: Kornberg Joshua (Director, CEO and President, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-03-31 Stock Option (right to buy) $3.45 A 1449 Acquired 2025-03-31 Common Stock, $.01 par value (1449) Direct